Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1978 2
1979 1
1980 2
1981 2
1982 1
1983 2
1984 2
2017 1
2019 1
2020 2
2021 6
2022 6
2023 5
2024 5
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
Severe Covid-19 GWAS Group; Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernández J, Prati D, Baselli G, Asselta R, Grimsrud MM, Milani C, Aziz F, Kässens J, May S, Wendorff M, Wienbrandt L, Uellendahl-Werth F, Zheng T, Yi X, de Pablo R, Chercoles AG, Palom A, Garcia-Fernandez AE, Rodriguez-Frias F, Zanella A, Bandera A, Protti A, Aghemo A, Lleo A, Biondi A, Caballero-Garralda A, Gori A, Tanck A, Carreras Nolla A, Latiano A, Fracanzani AL, Peschuck A, Julià A, Pesenti A, Voza A, Jiménez D, Mateos B, Nafria Jimenez B, Quereda C, Paccapelo C, Gassner C, Angelini C, Cea C, Solier A, Pestaña D, Muñiz-Diaz E, Sandoval E, Paraboschi EM, Navas E, García Sánchez F, Ceriotti F, Martinelli-Boneschi F, Peyvandi F, Blasi F, Téllez L, Blanco-Grau A, Hemmrich-Stanisak G, Grasselli G, Costantino G, Cardamone G, Foti G, Aneli S, Kurihara H, ElAbd H, My I, Galván-Femenia I, Martín J, Erdmann J, Ferrusquía-Acosta J, Garcia-Etxebarria K, Izquierdo-Sanchez L, Bettini LR, Sumoy L, Terranova L, Moreira L, Santoro L, Scudeller L, Mesonero F, Roade L, Rühlemann MC, Schaefer M, Carrabba M, Riveiro-Barciela M, Figuera Basso ME, Valsecchi MG, Hernandez-Tejero M, Acosta-Herrera M… See abstract for full author list ➔ Severe Covid-19 GWAS Group, et al. N Engl J Med. 2020 Oct 15;383(16):1522-1534. doi: 10.1056/NEJMoa2020283. Epub 2020 Jun 17. N Engl J Med. 2020. PMID: 32558485 Free PMC article.
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer.
McDaid WJ, Wilson L, Adderley H, Martinez-Lopez A, Baker MJ, Searle J, Ginn L, Budden T, Aldea M, Marinello A, Aredo JV, Viros A, Besse B, Wakelee HA, Blackhall F, Castillo-Lluva S, Lindsay CR, Malliri A. McDaid WJ, et al. Among authors: marinello a. Mol Cancer. 2024 Nov 12;23(1):253. doi: 10.1186/s12943-024-02157-x. Mol Cancer. 2024. PMID: 39533328 Free PMC article.
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study.
Lorusso R, De Piero ME, Mariani S, Di Mauro M, Folliguet T, Taccone FS, Camporota L, Swol J, Wiedemann D, Belliato M, Broman LM, Vuylsteke A, Kassif Y, Scandroglio AM, Fanelli V, Gaudard P, Ledot S, Barker J, Boeken U, Maier S, Kersten A, Meyns B, Pozzi M, Pedersen FM, Schellongowski P, Kirali K, Barrett N, Riera J, Mueller T, Belohlavek J; EuroECMO-COVID Study Group. Lorusso R, et al. Lancet Respir Med. 2023 Feb;11(2):151-162. doi: 10.1016/S2213-2600(22)00403-9. Epub 2022 Nov 16. Lancet Respir Med. 2023. PMID: 36402148 Free PMC article.
In-hospital outcomes and 6-month follow-up results of patients supported with extracorporeal membrane oxygenation for COVID-19 from the second wave to the end of the pandemic (EuroECMO-COVID): a prospective, international, multicentre, observational study.
De Piero ME, Mariani S, van Bussel BCT, Jarczak D, Krenner N, de la Sota EP, Silva PE, Roemmer M, Kowalewski M, Carelli S, Broman LM, Vuylsteke A, Fortuna P, Alessandri F, Martucci G, Patel BV, Lotz G, Boeken U, Maier S, Filip B, Meyns B, Haenggi M, Puss S, Schellongowski P, Kirali K, Bolotin G, Barrett N, Riera J, Mueller T, Belohlavek J, Lorusso R; EuroECMO-COVID Study Group. De Piero ME, et al. Lancet Respir Med. 2025 Apr;13(4):307-317. doi: 10.1016/S2213-2600(24)00369-2. Epub 2025 Feb 23. Lancet Respir Med. 2025. PMID: 40010369
Expression of Membrane Targets for Therapeutics in RET-Positive Non-Small Cell Lung Cancer.
Marinello A, Ghigna MR, Rotow JK, Adeyelu T, Metro G, Brandão M, Guisier F, Monnet I, Gaultier de Saint Basile H, Genova C, Raimbourg J, Terrisse S, Godefroy K, Toschi L, Mandarano M, Doubre H, Russo A, Valent A, Naqash AR, Aijaz A, Gazzah A, Remon J, Vanderwalde A, Elliott A, Halmos B, Barlesi F, Planchard D, Jänne PA, Besse B, Aldea M. Marinello A, et al. JAMA Oncol. 2025 Jul 1;11(7):762-770. doi: 10.1001/jamaoncol.2025.1293. JAMA Oncol. 2025. PMID: 40440007
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms.
Marinello A, Parisi C, Vasseur D, Combarel D, Bihoreau J, Lavaud P, Ezzedine R, Zullo L, Friboulet L, Zalcman G, Italiano A, Besse B, Aldea M. Marinello A, et al. JTO Clin Res Rep. 2024 Nov 22;6(3):100773. doi: 10.1016/j.jtocrr.2024.100773. eCollection 2025 Mar. JTO Clin Res Rep. 2024. PMID: 39990136 Free PMC article.
AP1-mediated reprogramming of EGFR expression triggers resistance to BLU-667 and LOXO-292 in RET-rearranged tumors.
Esposito D, Ascione CM, Belli S, Napolitano F, Servetto A, Pepe F, Malapelle U, Iaccarino A, Troncone G, Barone D, Bria E, Ferrara R, Lorenzini D, Lo Russo G, Ghigna MR, Marinello A, Aldea M, Besse B, Formisano L, Bianco R. Esposito D, et al. Among authors: marinello a. J Exp Clin Cancer Res. 2025 May 22;44(1):154. doi: 10.1186/s13046-025-03392-w. J Exp Clin Cancer Res. 2025. PMID: 40405293 Free PMC article.
BRAF Kinase Domain Duplication as a Potential On-Target Resistance Mechanism After Dabrafenib-Trametinib Therapy in a Patient With BRAFV600E-Mutated Lung Adenocarcinoma.
de Priester P, Zullo L, Vasseur D, Alonso De Castro B, Marinello A, Friboulet L, Planchard D, Besse B, Aldea M. de Priester P, et al. Among authors: marinello a. JCO Precis Oncol. 2025 Apr;9:e2400694. doi: 10.1200/PO-24-00694. Epub 2025 Apr 16. JCO Precis Oncol. 2025. PMID: 40239137 No abstract available.
43 results